<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Authors on </title>
    <link>https://shansabri.github.io/authors/</link>
    <description>Recent content in Authors on </description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    
	    <atom:link href="https://shansabri.github.io/authors/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title></title>
      <link>https://shansabri.github.io/authors/admin/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://shansabri.github.io/authors/admin/</guid>
      <description>&lt;p&gt;As a scientist of computational biology at &lt;a href=&#34;https://sana.com/&#34; target=&#34;_blank&#34;&gt;Sana&lt;/a&gt;, Shan leads bioinformatics efforts in pre-clinical studies for Sanaâ€™s hypoimmune PSC-derived pancreatic islet cell therapy, in development for the treatment of type 1 diabetes; see &lt;a href=&#34;https://sana.com/our-pipeline/&#34; target=&#34;_blank&#34;&gt;SC451&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;Prior to Sana, he leveraged novel high-throughput approaches at &lt;a href=&#34;https://arsenalbio.com/&#34; target=&#34;_blank&#34;&gt;ArsenalBio&lt;/a&gt; to better understand and engineer the immune system to eradicate solid tumors.&lt;/p&gt;

&lt;p&gt;Shan has completed his PhD in the labs of &lt;a href=&#34;https://plathlab.dgsom.ucla.edu/pages/&#34; target=&#34;_blank&#34;&gt;Kathrin Plath&lt;/a&gt; and &lt;a href=&#34;http://www.biolchem.ucla.edu/labs/ernst/&#34; target=&#34;_blank&#34;&gt;Jason Ernst&lt;/a&gt; at UCLA where he applied multi-omic assays and developed novel computational methods to establish universal principles of cell fate transitions using somatic-to-iPSC conversion as a platform.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
